Nalaganje...
Salvage Therapy of Refractory Hemophagocytic Lymphohistiocytosis with Alemtuzumab
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that remains difficult to treat. Even with current standard HLH therapy, only approximately half of patients will experience complete resolution of disease, and early mortality remains a significant...
Shranjeno v:
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2012
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410971/ https://ncbi.nlm.nih.gov/pubmed/22522603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24188 |
Oznake: |
Označite
Brez oznak, prvi označite!
|